EVIDENCE LIBRARY
Deprescribing Policy Review Found That Reduced Sedative Prescribing Could Be Accompanied by Substitution
An international policy review considered both intended and unintended consequences. Fewer prescriptions for one product did not necessarily mean less overall sedative harm.
An international policy review considered both intended and unintended consequences. Fewer prescriptions for one product did not necessarily mean less overall sedative harm.
The policy patterns
The review described monitoring programs, insurance restrictions, prescriber incentives, education, and scheduling changes. Some policies reduced recorded use but shifted treatment to other medicines or increased out-of-pocket spending.
The authors emphasized substitution after alprazolam restrictions and the need to examine outcomes beyond the targeted drug count.
Comparisons were heterogeneous
Much of the underlying evidence was observational and retrospective, and unintended effects were not consistently assessed. Policies operated in different systems and periods.
The review cannot establish a single best rule for every jurisdiction or attribute a particular death to one policy. Forensic and policy interpretation should retain changes in total exposure, alternatives, access, and clinical outcomes. A successful numerical reduction in one benzodiazepine measure is different from demonstrated improvement in overall patient safety.
Source paper
Original analysis of the supplied journal article, identified as PMC7008681.